4.2 Article

Differential profiles of HDAC1 substrates and associated proteins in breast cancer cells revealed by trapping

期刊

MOLECULAR OMICS
卷 17, 期 4, 页码 544-553

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/d0mo00047g

关键词

-

资金

  1. National Institutes of Health [GM131821, GM121061]
  2. Karmanos Cancer Institute Proteomics Core - NIH [P30 ES020957, P30 CA022453, S10 OD010700]
  3. Wayne State University

向作者/读者索取更多资源

Histone deacetylase (HDAC) proteins, which regulate the acetylation state of proteins, have different roles in the progression of various cancer types and show distinct effects in breast cancer cells. Comparing the associated protein profiles of HDAC1 in different breast cancer cell lines revealed variable roles indicating potential impact on cancer aggressiveness and drug sensitivity.
Histone deacetylase (HDAC) proteins, which regulate the acetylation state of proteins, are the targets of multiple clinical drugs for cancer treatment. Due to the heterogeneity of tumors, HDAC proteins play different roles in the progression of various cancer types. For example, MDA-MB-468 and MDA-MB-231 cells are both triple negative breast cancer cells but belong to different subtypes that display different response to HDAC inhibitor drugs. To investigate the role of HDAC proteins in breast cancer, the substrate and associated proteins of HDAC1 in MDA-MB-231, MDA-MB-468, and a normal breast epithelial cell line, MCF10A, were analyzed using substrate trapping mutants and proteomics-based mass spectrometry. All three cell lines demonstrated nonoverlapping substrate protein profiles. While both normal MCF10A and cancerous MDA-MB-468 cell lines contained similar HDAC1 associated proteins, including proteins associated with epigenetic and RNA processing mechanisms, the HDAC1 associated protein profile of MDA-MB-231 cells was devoid of expected epigenetic proteins. The variable associated protein profiles of MDA-MB-231 and MDA-MB-468 suggest that HDAC1 plays distinct roles in breast cancer cell biology, which might affect cancer aggressiveness and HDAC inhibitor sensitivity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据